Editorial: Sorafenib Toxicity, a Biomarker of Effect? Authors’ Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14067
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Sorafenib Toxicity, a Biomarker of Effect?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Are Sorafenib-Related Adverse Events Associated With Prolonged Survival? Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Editorial: Suicide and IBD-a Call to Action. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Editorial: Covert Hepatic Encephalopathy-Silent but Serious. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: Moving Towards a Robust Definition of Sarcopenia in Cirrhosis-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Editorial: Refractory GERD-good Drug, Wrong Patients? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Editorial: Helicobacter Pylori Resistance and Sequential Therapy-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: Treating Strictures in Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Cytokeratin-18 as a Biomarker of Hepatocellular Carcinoma Regression After Transarterial Chemoembolization. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy